Integrating clinical research into the health care ecosystem improves patient engagement and quality of care while reducing costs, though only 1% of the general population participates in clinical trials.
Evotec and Almirall are using a novel approach to disrupt cell signaling to discover and develop first-in-class therapeutics targeting dermatology diseases.
MannKind Corporation, of Afrezza fame, and United Therapeutics have signed an exclusive licensing and collaboration agreement for dry powder pulmonary hypertension products.
The global biopharmaceutical services provider has launched the Patient Innovation Center to help sponsors implement patient-centric initiatives — an area in which the company is committed to innovate, says executive.
The US FDA announced a number of measures it considers as a viable means of combatting AMR, including the idea of hospitals paying a ‘subscription’ to access new medicines.
in-PharmaTechnologist (IPT) speaks to Ettore Cucchetti (EC), CEO of ACGI, about how the biopharma industry is adapting to the threat of counterfeit medicine and how he expects the industry will adopt further measures beyond those stipulated in the EU...
As Novartis looks to sell a major chunk of its generics portfolio in the US, in-PharmaTechnologist has a look back at some of the stories this year that have signposted larger, on-going trends in the US generics market.
Undisclosed pharmaceutical industry payments to authors of oncology clinical trials published in scientific journals raise concern around credibility and trustworthiness, according to a recent report.
Major pharmaceutical companies and CMOs in the US have announced emergency contingency plans, including facility closures and the relocation of drug products, as Hurricane Florence approaches southeastern shores.
Jiangsu Yew Pharmaceutical outright refused permission for inspectors from Hungary to visit its site, resulting in the suspension of the company’s marketing authorisation.
Through XpertDox’s partnership with the Heart Failure Society of America (HFSA), patients and clinicians will be able to track heart failure related clinical trials.
Three family members charged with producing and supplying unlicensed medicines in the UK used pressing equipment and dyes imported from China, says MHRA.
BioIVT’s research on the mechanisms underlying the C-DILI assay introduces “a new paradigm,” which suggests BSEP inhibition alone will not lead to bile acid-induced liver injury, says study director.
The biopharmaceutical analytical and bioanalytical contract solutions provider SGS is investing more than $1.7m to expand its North American biopharmaceutical testing capabilities.
The top three myths of ‘going digital’ relate to the industry’s self-image, the perceived role of technology, and current market conditions – still, digital is not a fad and is here to stay, says industry expert.
The collaboration will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet clinical trial management system (CTMS).
A study at Washington University in St. Louis has shown a new way to deliver drugs to the brainstem in a non-invasive administration: microbubbles and ultrasound.
Virtrial’s vision is to replace up to half of the standard clinical trial visits with virtual ones, using a hybrid approach incorporating telemedicine.
The digital health company Antidote Technologies is partnering with PWNHealth, a virtual care company that provides direct-to-patient (DTP) lab services.
DZS Clinical Services has been acquired by the global CRO WDMD in a deal that will expand its service offerings globally with the addition of coverage in Europe and Japan.
The Nuvisan Group is taking on part of Galderma’s R&D capacities site, growing its service lines in bioanalysis, clinical trial supplies, and pharmaceutical analytics
In Novartis’ latest restructuring move for 2018, the pharma giant announced plans to sell US generic oral solids and dermatology businesses to Aurobindo Pharma US.
This month marked the effective start date for Parexel's new executive VP and CFO Greg Rush, who joins August's People on the Move with several other c-suite hires, including a new CEO at Citoxlab and COO at ProSciento.
IRBM and Merck have signed a new agreement in the peptide therapeutics area through which the Italian CRO will identify potential peptide leads for a specific Merck target.
The outsourced service providers have signed a new collaboration agreement to provide global pharmaceutical and biotechnology clients access to electrophysiology and ion channel screening.
The contract services provider is now collecting and using peripheral blood mononuclear cells (PBMCs) for early phase clinical trials at its Antwerp, Belgium-based Clinical Pharmacology Unit (CPU).
Alcami is working with a local university on a program designed to enhance biomanufacturing workforce education and prepare students for careers in the industry.
